Abstract
Microbial products are surveyed that have an immunoregulatory activity, both from the realm of low-molar-mass compounds and from the group of naturally occurring polymers. The data include in most cases the producer organism or source, a brief chemical characteristic and biological activity. Various groups of substances are compared, the drawbacks attendant on their acquisition and application are pointed out and their advantageous properties are specified.
Similar content being viewed by others
Abbreviations
- AbFC:
-
antibody-forming cells
- ADCC:
-
antibody-dependent cell mediated cytotoxicity
- BCGF:
-
B-cell growth factor
- DOPA:
-
3,4-dihydroxyphenylalanine
- DTH:
-
delayed-type hypersensitivity
- ELISA:
-
enzyme-linked immunosorbent assay
- GvHR:
-
graft-vs.-host reaction
- HIV:
-
human immunodeficiency virus
- Ig:
-
immunoglobulin
- IFN:
-
interferon
- IL-1, IL-2, IL-3:
-
interleukins 1, 2 and 3
- LPS:
-
lipopolysaccharide
- MDP:
-
muramyl dipeptide
- MΦ:
-
macrophages
- NCWS:
-
Nocardia-cell wall skeleton
- NDCM:
-
Nocardia-delipidated cell mitogen
- NK:
-
natural killers
- NWSM:
-
Nocardia water-soluble mitogen
- NWSMP:
-
Nocardia water-soluble pellet
- PWM:
-
pokeweed mitogen
- SRBC:
-
sheep red blood cells
References
Aoyagi T., Tobe H., Kojima F., Hamada M., Takeuchi T., Umezawa H.: Amastatin, an inhibitor of aminopeptidase A, produced by actinomycetes.J. Antibiot. 31, 636–638 (1978a).
Aoyagi T., Yamamoto T., Kojiri K., Kojima F., Hamada M., Takeuchi T., Umezawa H.: Forphenicine, an inhibitor of alkaline phosphatase produced by actinomycetes.J. Antibiot. 31, 244–246 (1978b).
Azuma I., Taniyama T., Yamawaki M., Sugimura K., Yamamura Y.: Adjuvant and antitumor activities ofNocardia cell-wall skeletons.Gann 67, 733–736 (1976).
Barot-Ciorbaru R., Brochier J., Miyawaki T., Pred'homme J.L., Peitt J.F. Bona C., Taniguchi N., Revillard J.P.: Stimulation of human B lymphocytes byNocardia-delipidated cell mitogen and derived fractions fromN. opaca. Structure-activity relationship.J. Immunol. 135, 3277–3283 (1985).
Barot-Ciorbaru R., Cornil I., Grand-Perret T., Poupon M.F.: Antimetastatic effect of immunomodulators fromNocardia opaca in mice and rats activation of peritoneal macrophages by these fractions.Cancer Immunol Immunother.25, 111–118 (1987).
Barot-Ciorbaru R., Wietzerbin J., Peitt J.F., Chedid L., Falcoff E., Lederer E.: Induction of interferon synthesis in mice by fractions fromNocardia.Infect. Immun. 19, 353–356 (1978).
Berger J., Goldberg M.W.: Borrelidin a new antibiotie with high antiborrelia activity and penicillin enhancement properties.J. Clin. Invest. 28, 1046–1051 (1949).
Ciorbaru R., Adam A., Peitt J.F., Lederer E., Bona C., Chedid L.: Isolation of mitogenic and adjuvant active fractions from various species ofNocardiae Infect. Immun. 11, 257–264 (1975).
Ciorbaru R., Peitt J.F., Lederer E., Zissman E., Bona C., Chedid L.: Presence and subcellular localization of two distinct mitogenic fractions in the cells ofNocardia rubra andNocardia opaca: preparation of soluble mitogenic peptidoglycan fractions.Infect. Immun. 13, 1084 (1976).
Dreyfuss M., Harri E., Hofmann H., Kobel H., Pache W., Tscherter H.: Cyclosporin A and C new metabolites fromTrichoderma polysporum (Link exPers.)Rifai.Eur. J. Microbiol. 3, 125–133 (1976).
Gotoh T., Nakahara K., Nishiura T., Hashimoto M., Kinot T., Kuroda Y., Okuhara M., Kohsaka M., Aoki H., Imanaka H.: Studies on a new immunoactive peptide, FK-156. II. Fermentation, extraction and chemical and biological characterization.J. Antibiot. 35, 1286–1292 (1982).
Hatanaka H., Kino T., Miyata S., Inamura N., Kuroda A., Goto T., Tanaka H., Okuhara M.: FR-900520 and FR-900523, novel immunosuppressants isolated from a streptomyces II. Fermentation, isolation and physico-chemical and biological characteristics.J. Antibiot. 41, 1592–1601 (1988).
Hofman, J.: Bacterial endotoxins, pp. 655–682 inHandbook of Toxinology (W.T. Shier, D. Mebs, Eds). Marcel Dekker, New York 1990.
Hofman J., Pospíšil M., Mára M., Hříbalová V.: Phenol-water extracts of gram-positiveListeria monocytogenes and gram-negativeSalmonella typhimurium. Comparison of biological activities.Folia Microbiol. 30, 231–236 (1985).
Hong K., Kinoshita T., Miyazaki W., Izawa T., Inoue K.: An anticomplementary agent, K-7 monocarboxylic acid: Its site and mechanism of inhibition of the complement activation cascade.J. Immunol. 122, 2418–2423 (1979).
Ishizuka M., Sato J., Sugiyama Y., Takeuchi T., Umezawa H.: Mitogenic effect of testation of lymphocytes.J. Antibiot. 33, 653–662 (1980).
Ishizuka M., Masuda T., Kanbayashi N., Watanabe Y., Matsuzaki M., Sawazaki Y., Ohkura A., Takeuchi T., Umezawa H.: Antitumor effect of forphenicinol, a low molecular weight immunomodifier, on murine transplantable tumors and microbial infections.J. Antibiot. 35, 1049–1054 (1982).
Ishizuka M., Takeuchi T., Masuda T., Fukusawa S., Umezawa H.: Enhancement of immune responses and possible inhibition of suppressor cells by aclacinomycin. A.J. Antibiot. 34, 331–340 (1981).
Ivanitskaya L.P., Oparina O.N., Stekhanova T.N., Navashin S.M.: Low molecular immunomodifiers of natural origin.Antibiotiki 30, 131–138 (1985).
Iwami M., Nakayama O., Terano H., Koshaka M., Oaki H., Imanaka H.: A new immunomodulator, FR-900494: Taxonomy, fermentation, isolation and physico-chemical and biological characteristics.J. Antibiot. 40, 612–622 (1987).
Izumi S., Ueda H., Okuhara M., Aoki H., Yamamura Y.: Effect ofNocardia rubra cell wall skeleton on murine interferon productionin vitro.Cancer Res.,46, 1960–1969 (1986).
Kaneko I., Kamoshida K., Takahashi S.: Complestatin, a potent anti-complement substance produced byStreptomyces lavendulae. I. Fermentation, isolation and biological characterization.J. Antibiot. 42, 236–241 (1989).
Kawai Y., Nakahara K., Gotoh T., Uchida I., Tanaka H., Imanaka H.: Studies on a new immunoactive peptide, FK-156 III. Structure elucidation.J. Antibiot. 35, 1293–1299 (1982).
Kayakiri H., Takase S., Shibata T., Okamoto M., Terano H. Hashimoto M.: Structure of kifunensine, a new immunomodulator isolater from an actinomycete.J. Org. Chem. 54, 4015–4016 (1989).
Keller-Schierlein N.: Stoffwechselprodukte von Mikroorganismen. 55. Über die Konstitution des Borrelidins.Helv. Chim. Acta 50, 731–753 (1967).
Keller-Schierlein W., Wuthier D., Drantz H.: (3S, 8E)-1,3-dihydroxy-8-decen-5-one, ein Stoffwechselprodukt vonStreptomyces fimbriatus (Millard und Bur 1926).Helv. Chim. Acta 66, 1253–1261 (1983).
Khurnova L.M., Ivanitskaya L.P.: Low-molecular immunomodulators from microorganisms.Antibiotiki 34, 786–792 (1989).
Kinashi H., Someno K., Sakaguchi K., Higashijima T., Miyazawa T.: Structure of concanamycin A.Tetrahedron Lett. 22, 3861–3864 (1981).
Kinashi H., Sakaguchi K.: Structures of concanamycins B and C.J Antibiot. 35, 1618–1620 (1982).
Kinashi H., Someno K., Sakaguchi K.: An antimitogenic agent of mouse lymphocytes produced by a streptomycete S-45.Abstr. Papers Ann. Meet. Agric. Chem. Soc. Japan, p. 515, Fukuoka 1980.
Kino T., Hatanaka H., Hashimoto M., Nishiyama M., Goto T., Okuhara M., Kohsaka M., Aoki H., Imanaka H.: FK-506, a novel immunosuppressant isolated from a streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.J. Antibot. 40, 1249–1255 (1987).
Koyama S., Ozaki A., Iwasaki Y., Sakita T., Osuga T., Watanabe A., Suzuki M., Kawasaki T., Soma T., Tabuchi T., Nakayama M., Koizumi S., Yokoyama K., Uchida T., Orii K., Tanaka T.: Randomized controlled study of post-operative adjuvant immunochemotherapy withNocardia rubra cell wall skeleton (N-CWS) and Tegafur for gastric carcinoma.Cancer Immunol. Immunother. 22, 148–154 (1986).
Lüderitz O., Freudenberg M.A., Galanos C., Lehmann V., Rietschel E.T., Shaw D.H.: Lipopolysaccharides of gram-negative bacteria.Curr. Topics Membr. Transport 17, 79–151 (1982).
Mine Y., Yokota Y., Fukada S., Nishida M., Goto S., Kuwahara S.: Immunoactive peptides, FK-156 and FK-565. I. Enhancement of host resistance to microbial infection in mice.J. Antibiot. 36, 1045–1050 (1983).
Mizutani S., Odai H., Masuda T., Lijima M., Osono M., Hamada M., Naganawa H., Ishizuka M., Takeuchi T.: Biological activities of IC201 (3S,8E)-1,3-dihydroxy-8-decen-5-one), a low molecular weight immunomodulator produced byStreptomyces.J. Antibiot. 42, 952–959 (1989).
Nakamura A., Nagai K., Ando K., Tamura G.: Selective suppression by prodigiosin of the mitogenic response of murine splenocytes.J. Antibiot. 39, 1155–1159 (1986).
Nakamura A., Nagai K., Suzuki S., Ando K., Tamura G.: A novel method of screening for immunomodulating substances, establishment of an assay system and its application to culture broth of microorganisms.J. Antibiot. 39, 1148–1154 (1986).
Nemoto K., Hayashi M., Sugawara Y., Abe F., Takita T., Takeuchi T.: Effects of deoxyspergualin on hematopoiesis: Studies on murine hematopoietic progenitor cell and peripheral blood cell levels.J. Antibiot. 42, 312–316 (1989).
Ohno R., Nakamura H., Kodera Y., Ezaki K., Yokomaku S., Oguma S., Kubota Y., Shibata H., Ogawa N., Masaoka T., Yamada K.: Randomized controlled study of chemoimmunothezapy of acute myelogenous leukemia (AML) in adults withNocardia rubra cell-wall skeleton and irradiated allogenic AML cells.Cancer 57, 1483–1488 (1986).
Okura A., Nakadaira M., Naito K., Ishizuka M., Takeuchi T., Umezawa H.: Effect of forphenicinol on γ-interferon production in mice sensitized with BCG.J. Antibiot. 39, 569–574 (1986).
Ratliff D.A., Carr N., Cochrane J.P.S.: Rectal stricture due to actinomycosis.Brit. J. Surg. 73, 589–590 (1986).
Ryffel B.: Experimental toxicological studies with cyclosporin A pp. 45–75 inCyclosporin A. Proc. Internat. Conf. Cyclosporin A (D.J.G. White, Ed.), Elsevier Biomedical Press, Amsterdam 1982.
Sakatani M., Ogura T., Masuno T., Kishimoto S., Yamamura Y.: Effect ofNocardia rubra cell wall skeleton on augmentation of cytotoxicity function in human pleural macrophages.Cancer Immunol. Immunother. 25, 119–125 (1987).
Sato H., Ochiai T., Sato H., Hayashi R., Watanabe K., Asano T., Isono K., Tanaka T.: Result of randomized clinical trial of immunotherapy withNocardia rubra-CWS on postoperable gastric cancer patients.J. Japan Surg. Soc. 83, 635–648 (1982).
Shibuya K., Hayashi E., Abe F., Takahashi K., Horinishi H., Ishizuka M., Takeuchi T., Imezawa H.: Enhancement of the interleukin-1 and interleukin-2 releases by ubenimex.J. Antibiot. 40, 363–369 (1987).
Sone, S., Fidler I.J.: In situactivation of tumoricidal properties in rat alveolar macrophages and rejection of experimental lung metastases by intravenous injections ofNocardia rubra cell wall skeleton.Cancer Immunol. Immunother. 12, 203–209 (1982).
Šterzl J., Řeháček Z., Cudlín J.: Regulation of immune response by ergot alkaloids.J. Czech. Med. 10, 90–98 (1987).
Takeuchi T., Iinuma H., Kunimoto S., Masuda T., Ishizuka M., Takeuchi M., Hamada M., Naganawa H., Kondo S., Umezawa H.: A new antitumor antibiotic, spergualin: Isolation and antitumor activity.J. Antibiot. 34, 1619–1621 (1981).
Takeuchi T., Takahashi S., Iinuma H., Umezawa H.: Diketocoriolin B, an, active derivative of coriolin B produced byCoriolus consors.J. Antibiot. 24, 631–635 (1971).
Tanaka H., Kuroda A., Marusawa H., Hashimoto M., Hatanaka H., Kino T., Goto T., Okuhara M.: Physicochemical properties of FK-506, a novel immunosuppressant isolated fromStreptomyces tsukubaensis.Transplant. Proc. 19, 11–16 (1987).
Tlaskalová-Hogenová H., Bártová J., Mrklas L., Mančal P., Broukal Z., Barot-Ciorbaru R., Novák M., Hanikýřová M.: Stimulation of human blood lymphocyte by different polyclonal B cell activators of bacterial and plant origin: Production of IgM, IgG and IgA estimated by the ELISA method.Folia Microbiol. 30, 258–266 (1985).
Umezawa H., Aoyagi T., Hazato T., Uotani K., Hamada M., Takeuchi T.: Esterastin, an inhibitor of esterase, produced by actinomycetes.J. Antibiot. 31, 639–641 (1978).
Umezawa H., Aoyagi T., Suda H., Hamada M., Takeuchi T.: Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes.J. Antibiot. 29, 97–99 (1976).
Umezawa H., Aoyagi T., Uotani K., Hamada M., Takeuchi T., Takanashi S.: Ebelactone, an inhibitor of esterase, produced by actinomycetes.J. Antibiot. 33, 1594–1598 (1980).
Umezawa H., Kondo S., Iinuma H., Kunimoto S., Ikeda Y., Iwasawa H., Ikeda D., Takeuchi T.: Structure of an antitumor antibiotic, spergualin.J. Antibiot. 34, 1622–1624 (1981).
Westley J.W., Liu C.M., Sello L.H., Evans A.H., Troupe N., Blount J.F., Chiu A.M., Todaro L.J., Miller P.A.: The structure and absolute configuration of the 18-membered macrolide lactone antibiotic X-4357B (concanamycin A).J. Antibiot. 37, 1738–1740 (1984).
Yamaguchi T., Ichimaru M., Kohno F., Takatsuki K., Kishimoto S., Araki K., Tomosue H., Takada M., Matsumoto M., Yuki K., Nishioka K., Hashimoto S., Ogawa N.: Adjuvant activity ofNocardia cell-wall skeleton on maintenance chemotherapy and acute non-lymphatic leukemia.Acta Haematol. Japan 46, 1096–1098 (1983).
Yamakido M., Yanagida J., Ishioka S., Matsuzaka S., Hozawa S., Takaishi M., Akiyama M., Nishimoto Y.: Effects ofNocardia rubra cell wall skeleton on lymphocyte subsets in former poison gas factory workers.Japan J. Cancer Res. (Gann) 76, 1091–1098 (1985).
Yamakido M., Yanagida J., Ishioka S., Matsuzaka S., Hozawa S., Takaishi M., Akiyama M., Nishimoto Y.: Effects ofNocardia rubra cell wall skeleton on interleukin 2 production and lymphocyte proliferation in former poison gas factors workers.Japan. J. Cancer. Res. (Gann) 77, 406–412 (1986).
Yamamura Y., Ogura T., Sakatani M., Hirao F., Kishimoto S., Fukuoka M., Takada M., Kawahara M., Furuse K., Kuwahara O., Ikegami H., Ogawa N.: Randomized controlled study of adjuvant immunotherapy withNocardia rubra cell wall skeleton for inoperable long cancer.Cancer Res. 43, 5575–5579 (1983).
Yokota Y., Mine Y., Wakai Y., Watanabe Y., Nishida M., Gota S., Kawahara S.: Immunoactive peptides, FK-156 and FK-565. II. Restoration of host resistance to microbial infection in immunosuppressed mice.J. Antibiot. 36, 1051–1058 (1983).
Author information
Authors and Affiliations
Additional information
Translated by K. Sigler
Rights and permissions
About this article
Cite this article
Vaněk, Z., Matějů, J. & Čurdová, E. Immunomodulators isolated from microorganisms. Folia Microbiol 36, 99–111 (1991). https://doi.org/10.1007/BF02814487
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02814487